Risk of psychiatric disorders following polycystic ovary syndrome: A nationwide population-based cohort study

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Hung, Jeng Hsiu ^a,b   Hu, Li Yu ^c,i   Tsai, Shih Jen ^d,i   Yang, Albert C ^d,e,i   Huang, Min Wei ^f   Chen, Pan Ming ^d   Wang, Shu Li ^g   Lu, Ti ^c   Shen, Cheng Che ^f,h,i  

^a TAIPEI TZU CHI HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g Central Taiwan University of Sciences and Technology   (Taiwan)

^h NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

ⁱ NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENTAL DISEASE; OVARY POLYCYSTIC DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SLEEP DISORDER; CASE CONTROL STUDY; COMPLICATION; MENTAL DISORDERS; POLYCYSTIC OVARY SYNDROME; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; TAIWAN;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MENTAL DISORDERS; POLYCYSTIC OVARY SYNDROME; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TAIWAN;

EID: 84901193891     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097041     Document Type: Article

References (41)

1. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333: 853-861.
2. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, et al. (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91: 456-488.
3. Dunaif A, Segal KR, Futterweit W, Dobrjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165-1174. (Pubitemid 19250404)
4. Bentley-Lewis R, Seely E, Dunaif A (2011) Ovarian hypertension: polycystic ovary syndrome. Endocrinol Metab Clin North Am 2011 Jun;40: 433-449.
5. Rassi A, Veras AB, dos Reis M, Pastore DL, Bruno LM, et al. (2010) Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry 51: 599-602.
6. Mansson M, Holte J, Landin-Wilhelmsen K, Dahlgren E, Johansson A, et al. (2008) Women with polycystic ovary syndrome are often depressed or anxious - a case control study. Psychoneuroendocrinology 33: 1132-1138.
7. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A (2007) Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 87: 1369-1376. (Pubitemid 46829130)
8. Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, et al. (2003) Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 74: 299-304. (Pubitemid 36555931)
9. Klipstein KG, Goldberg JF (2006) Screening for bipolar disorder in women with polycystic ovary syndrome: a pilot study. J Affect Disord 91: 205-209. Epub 2006 Feb 2017.
10. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, et al. (2013) Psychological investigation in patients with polycystic ovary syndrome. Health Qual Life Outcomes 11: 141.
11. Acmaz G, Albayrak E, Acmaz B, Baser M, Soyak M, et al. (2013) Level of anxiety, depression, self-esteem, social anxiety, and quality of life among the women with polycystic ovary syndrome. ScientificWorldJournal 2013: 851815.
12. Soares CN (2013) Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management. Drugs Aging 30: 677-685.
13. Cirillo PC, Passos RB, Bevilaqua MC, Lopez JR, Nardi AE (2012) Bipolar disorder and Premenstrual Syndrome or Premenstrual Dysphoric Disorder comorbidity: a systematic review. Rev Bras Psiquiatr 34: 467-479.
14. Wu YC, Hill RA, Gogos A, van den Buuse M (2013) Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF. Neuroscience 239: 67-83.
15. Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, et al. (2012) Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 308: 1906-1914.
16. Database. NHIR National Health Research Institutes.
17. Rassi A, Veras AB, dos Reis M, Pastore DL, Bruno LM, et al. (2010) Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry 51: 599-602. doi: 510.1016/j.comppsych.2010.1002.1009. Epub 2010 Mar 1029.
18. Cinar N, Kizilarslanoglu MC, Harmanci A, Aksoy DY, Bozdag G, et al. (2011) Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod 26: 3339-3345. doi: 3310.1093/humrep/der3338. Epub 2011 Oct 3337.
19. Sonino N, Fava GA, Mani E, Belluardo P, Boscaro M (1993) Quality of life of hirsute women. Postgrad Med J 69: 186-189. (Pubitemid 23094646)
20. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, et al. (1999) The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 140: 672-676. (Pubitemid 29191387)
21. Kerchner A, Lester W, Stuart SP, Dokras A (2009) Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 91: 207-212. doi: 210.1016/j.fertnstert.2007. 1011.1022. Epub 2008 Feb 1014.
22. Himelein MJ, Thatcher SS (2006) Polycystic ovary syndrome and mental health: A review. Obstet Gynecol Surv 61: 723-732. (Pubitemid 44655530)
23. Weiner CL, Primeau M, Ehrmann DA (2004) Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 66: 356-362. (Pubitemid 38668404)
24. Oulis P, Masdrakis VG, Markianos M (2013) Testosterone and dehydroepiandrosterone sulfate in female anxious and non-anxious major depression. Int J Psychiatry Clin Pract 28: 28.
25. Annagur BB, Tazegul A, Uguz F, Kerimoglu OS, Tekinarslan E, et al. (2013) Biological correlates of major depression and generalized anxiety disorder in women with polycystic ovary syndrome. J Psychosom Res 74: 244-247. doi: 210.1016/j.jpsychores.2013.1001.1002. Epub 2013 Jan 1023.
26. Pan A, Ye X, Franco OH, Li H, Yu Z, et al. (2008) Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study. J Affect Disord 109: 75-82.
27. Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, et al. (2006) Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 63: 824-830.
28. Roberts RE, Deleger S, Strawbridge WJ, Kaplan GA (2003) Prospective association between obesity and depression: evidence from the Alameda County Study. Int J Obes Relat Metab Disord 27: 514-521. (Pubitemid 36520852)
29. Anderson SE, Cohen P, Naumova EN, Jacques PF, Must A (2007) Adolescent obesity and risk for subsequent major depressive disorder and anxiety disorder: prospective evidence. Psychosom Med 69: 740-747. (Pubitemid 350287481)
30. Sirmans SM, Pate KA (2013) Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 6: 1-13. eCollection 2013.
31. Legro RS, Gnatuk CL, Kunselman AR, Dunaif A (2005) Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 90: 3236-3242. Epub 2005 Mar 3229.
32. Legro RS, Blanche P, Krauss RM, Lobo RA (1999) Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors. Fertil Steril 72: 990-995.
33. Wild RA, Rizzo M, Clifton S, Carmina E (2011) Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 95: 1073-1079.e1071-1011. doi: 1010.1016/j.fertnstert.2010.1012.1027. Epub 2011 Jan 1017.
34. Cwikel J, Gidron Y, Sheiner E (2004) Psychological interactions with infertility among women. Eur J Obstet Gynecol Reprod Biol 117: 126-131. (Pubitemid 39487318)
35. Sahingoz M, Uguz F, Gezginc K, Korucu DG (2013) Axis I and Axis II diagnoses in women with PCOS. Gen Hosp Psychiatry 35: 508-511. doi: 510.1016/j.genhosppsych.2013.1004.1003. Epub 2013 May 1030.
36. Bilo L, Meo R (2008) Polycystic ovary syndrome in women using valproate: a review. Gynecol Endocrinol 24: 562-570.
37. Nandalike K, Agarwal C, Strauss T, Coupey SM, Isasi CR, et al. (2012) Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Sleep Med 13: 1307-1312.
38. Gateva A, Kamenov Z, Mondeshki T, Bilyukov R, Georgiev O (2013) [Polycystic ovarian syndrome and obstructive sleep apnea]. Akush Ginekol (Sofiia) 52: 63-68.
39. Shreeve N, Cagampang F, Sadek K, Tolhurst M, Houldey A, et al. (2013) Poor sleep in PCOS; is melatonin the culprit? Hum Reprod 28: 1348-1353.
40. de Sousa G, Schluter B, Buschatz D, Menke T, Trowitzsch E, et al. (2012) The impact of insulin resistance and hyperandrogenemia on polysomnographic variables in obese adolescents with polycystic ovarian syndrome. Sleep Breath 16: 169-175.
41. Haut ER, Pronovost PJ (2011) Surveillance bias in outcomes reporting. JAMA 305: 2462-2463. doi: 2410.1001/jama.2011.2822.